Bleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction: A real-life data

por Mustafa Kürşat Tigen, Mehmet Hasan Özdil, Altuğ Çinçin, Emre Gürel, Murat Sünbül, Anıl Şahin, Tuba Güçtekin, Zekeriya Doğan, Nurten Sayar, Beste Özben
Publicado 2021